“Since 2018, I have had the pleasure of working with the Ovata team members. They are customer focused, performance driven, delivering high quality work on time while exemplifying great teamwork. DalCor continues to benefit from the tailored infrastructure they put in place to support our company’s growth and financing through multiple rounds.”
“The team at Ovata has a deep understanding of what life science companies need to be successful. They excel at finding solutions to overcome the inevitable development hurdles and securing sufficient resources to accelerate programs.”
“The Ovata team has been instrumental in managing several Sanderling portfolio companies from creation through successful exit. They are true to their model – aligning themselves with the interests of management and investors of each company by providing cost effective support of therapeutic development and achievement of goals.
Working with this team, for more than twenty years, we have observed the team’s ability to develop accurate budgets and work those budgets so that the dollars raised are directed toward the goals of the company. The principals know the details of the drug development business so that the interactions with the board and the rest of management are positive and productive. At the governance level this team has consistently been able to predict needs, keep costs down, and finding ways of extending the cash runway.
Clearly a team that consistently represent clients’ unique interests, working as an integral part of the company and ready when needed.”
“I am very impressed with the commitment, openness, and professionalism of the Ovata team. Their experience and creativity played an important role in permitting two of my portfolio companies to prevail over the years.”
“Having collaborated with the team at Ovata on several financing and licensing deals, I appreciate their patience and resourcefulness during negotiation in an effort to reach an agreement that is a true win-win for all the parties.”
We provide strategic business guidance and financial expertise to enable emerging life science companies to accelerate the development of their discoveries.